Drug Type Induced pluripotent stem cells (iPSC), CAR-T |
Synonyms- |
Mechanism BCMA inhibitors(B-cell maturation protein inhibitors), CD16a modulators(Low affinity immunoglobulin gamma Fc region receptor III-A modulators), MICA inhibitors(MHC class I polypeptide-related sequence A inhibitors) + [2] |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Preclinical | US | 10 Nov 2022 |